Progesterone and FOXO1 signaling: Harnessing cellular senescence for the treatment of ovarian cancer

Collado, 2010, Senescence in tumours: evidence from mice and humans, Nat Rev Cancer, 10, 51, 10.1038/nrc2772

Diep, 2013, Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells, Cell Cycle, 12, 1433, 10.4161/cc.24550

Collado, 2000, Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1, J Biol Chem, 275, 21960, 10.1074/jbc.M000759200

Modugno, 2012, Hormone response in ovarian cancer: time to reconsider as a clinical target?, Endocr Relat Cancer, 19, R255, 10.1530/ERC-12-0175

Gellersen, 2009, Non-genomic progesterone actions in female reproduction, Hum Reprod Update, 15, 119, 10.1093/humupd/dmn044

Goto, 2008, Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells, Oncogene, 27, 9, 10.1038/sj.onc.1210626

Labied, 2006, Progestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium, Mol Endocrinol, 20, 35, 10.1210/me.2005-0275

Hirota, 2010, Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice, J Clin Invest, 120, 803, 10.1172/JCI40051